Answers are grounded in this paper and cite their sources.
Explores drug regimens and vaccination for cutaneous tuberculosis, indicating challenges and future directions.
Treatment of cutaneous tuberculosis (CTB) can be challenging due to multiple factors. We discuss the role of Bacillus Calmette Guérin vaccination in the prevention of CTB, complications associated with CTB, drug regimens used for treatment in adults and children, various challenges in the management, including drug resistance, existing lacunae, and future directions in the diagnosis and treatment of CTB.
No takes yet. Share an insight, caveat, or question.
Khullar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: